# AI for Rheumatology

## Description

Use machine learning to phenotype autoimmune disease, predict flares, forecast treatment response, and score joint inflammation.

## When to use

You are studying rheumatoid arthritis, systemic lupus erythematosus, spondyloarthritis, or other autoimmune rheumatic diseases and need predictive models for diagnosis, flares, or therapy selection.

## Usage

- Model disease activity with DAS28, CDAI, SLEDAI, and patient-reported outcomes.
- Integrate genetics, transcriptomics, cytokines, and autoantibody panels.
- Score ultrasound, MRI, and radiographic joint damage and inflammation.
- Predict response to biologics or JAK inhibitors and adverse events.
- Forecast flares from temporal clinical, lab, and patient-reported data.

## Steps

1. Curate EHR, multi-omics, imaging, and patient-reported data for the target rheumatic disease.
2. Define outcomes (flare, response, damage) and time windows for prediction.
3. Train predictive or image models and validate externally across sites.
4. Integrate predictions into treatment selection and flare monitoring workflows.
5. Address confounding from treatment effects using causal or time-varying methods.
6. Report subgroup performance and iterate with rheumatologist feedback.

## Code pattern

```python
import pandas as pd
from sklearn.ensemble import RandomForestClassifier

# Predict RA treatment response from clinical and serologic features
X = df[["das28", "crp", "rf", "anti_ccp", "prior_biologic", "erosion_count"]]
y = df["responded_to_tnf_inhibitor"]

model = RandomForestClassifier(class_weight="balanced", random_state=42)
model.fit(X, y)
print("Response probability:", model.predict_proba(X[:5])[:, 1])
```

## Tuning notes

- Rheumatic diseases are heterogeneous and low prevalence; use external validation.
- Treatment effects confound natural history; use causal or time-varying models.
- Imaging acquisition varies by machine and operator; normalize or calibrate across sites.
- Report subgroup performance by sex, ethnicity, and disease duration.

## Verification

1. Predict 12-month RA flare from EHR and patient-reported outcomes.
2. Classify SLE disease activity level and compare to SLEDAI scoring.
3. Quantify synovitis from ultrasound videos and validate against rheumatologist scores.

## References

- https://doi.org/10.3390/rheumato5040017
- https://lupus.bmj.com/content/11/1/e001140
- https://www.jrheum.org/content/49/11/1191
- https://doi.org/10.7759/cureus.99108
